Sanaz Memarzadeh, Ph.D. - Publications

Affiliations: 
2008 University of California, Los Angeles, Los Angeles, CA 
Area:
Molecular Biology

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Phan N, Hong JJ, Tofig B, Mapua M, Elashoff D, Moatamed NA, Huang J, Memarzadeh S, Damoiseaux R, Soragni A. A simple high-throughput approach identifies actionable drug sensitivities in patient-derived tumor organoids. Communications Biology. 2: 78. PMID 30820473 DOI: 10.1038/s42003-019-0305-x  0.4
2016 Smith DJ, Lin LJ, Moon H, Pham AT, Wang X, Liu S, Ji S, Rezek V, Shimizu S, Ruiz M, Lam J, Janzen DM, Memarzadeh S, Kohn DB, Zack J, et al. Propagating Humanized BLT Mice for the Study of Human Immunology and Immunotherapy. Stem Cells and Development. PMID 27608727 DOI: 10.1089/scd.2016.0193  0.52
2015 Soragni A, Janzen DM, Johnson LM, Lindgren AG, Thai-Quynh Nguyen A, Tiourin E, Soriaga AB, Lu J, Jiang L, Faull KF, Pellegrini M, Memarzadeh S, Eisenberg DS. A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas. Cancer Cell. PMID 26748848 DOI: 10.1016/j.ccell.2015.12.002  0.64
2015 Tiourin E, Velasco VS, Rosales MA, Sullivan PS, Janzen DM, Memarzadeh S. Tubal Ligation Induces Quiescence in the Epithelia of the Fallopian Tube Fimbria. Reproductive Sciences (Thousand Oaks, Calif.). PMID 25736327 DOI: 10.1177/1933719115574345  0.64
2015 Janzen DM, Tiourin E, Salehi JA, Paik DY, Lu J, Pellegrini M, Memarzadeh S. An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer Nature Communications. 6. DOI: 10.1038/ncomms8956  0.64
2013 Janzen DM, Paik DY, Rosales MA, Yep B, Cheng D, Witte ON, Kayadibi H, Ryan CM, Jung ME, Faull K, Memarzadeh S. Low levels of circulating estrogen sensitize PTEN-null endometrial tumors to PARP inhibition in vivo. Molecular Cancer Therapeutics. 12: 2917-28. PMID 24222661 DOI: 10.1158/1535-7163.MCT-13-0572  0.64
2013 Janzen DM, Rosales MA, Paik DY, Lee DS, Smith DA, Witte ON, Iruela-Arispe ML, Memarzadeh S. Progesterone receptor signaling in the microenvironment of endometrial cancer influences its response to hormonal therapy. Cancer Research. 73: 4697-710. PMID 23744837 DOI: 10.1158/0008-5472.CAN-13-0930  0.64
2013 Janzen DM, Cheng D, Schafenacker AM, Paik DY, Goldstein AS, Witte ON, Jaroszewicz A, Pellegrini M, Memarzadeh S. Estrogen and progesterone together expand murine endometrial epithelial progenitor cells. Stem Cells (Dayton, Ohio). 31: 808-22. PMID 23341289 DOI: 10.1002/stem.1337  0.64
2012 Paik DY, Janzen DM, Schafenacker AM, Velasco VS, Shung MS, Cheng D, Huang J, Witte ON, Memarzadeh S. Stem-like epithelial cells are concentrated in the distal end of the fallopian tube: a site for injury and serous cancer initiation. Stem Cells (Dayton, Ohio). 30: 2487-97. PMID 22911892 DOI: 10.1002/stem.1207  0.64
2012 Cai H, Memarzadeh S, Stoyanova T, Beharry Z, Kraft AS, Witte ON. Collaboration of Kras and androgen receptor signaling stimulates EZH2 expression and tumor-propagating cells in prostate cancer. Cancer Research. 72: 4672-81. PMID 22805308 DOI: 10.1158/0008-5472.CAN-12-0228  0.64
2011 Memarzadeh S, Cai H, Janzen DM, Xin L, Lukacs R, Riedinger M, Zong Y, DeGendt K, Verhoeven G, Huang J, Witte ON. Role of autonomous androgen receptor signaling in prostate cancer initiation is dichotomous and depends on the oncogenic signal. Proceedings of the National Academy of Sciences of the United States of America. 108: 7962-7. PMID 21518863 DOI: 10.1073/pnas.1105243108  0.64
2011 Cai H, Smith DA, Memarzadeh S, Lowell CA, Cooper JA, Witte ON. Differential transformation capacity of Src family kinases during the initiation of prostate cancer. Proceedings of the National Academy of Sciences of the United States of America. 108: 6579-84. PMID 21464326 DOI: 10.1073/pnas.1103904108  0.64
2010 Lukacs RU, Memarzadeh S, Wu H, Witte ON. Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation. Cell Stem Cell. 7: 682-93. PMID 21112563 DOI: 10.1016/j.stem.2010.11.013  0.64
2010 Memarzadeh S, Zong Y, Janzen DM, Goldstein AS, Cheng D, Kurita T, Schafenacker AM, Huang J, Witte ON. Cell-autonomous activation of the PI3-kinase pathway initiates endometrial cancer from adult uterine epithelium. Proceedings of the National Academy of Sciences of the United States of America. 107: 17298-303. PMID 20855612 DOI: 10.1073/pnas.1012548107  0.64
2010 Lawson DA, Zong Y, Memarzadeh S, Xin L, Huang J, Witte ON. Basal epithelial stem cells are efficient targets for prostate cancer initiation. Proceedings of the National Academy of Sciences of the United States of America. 107: 2610-5. PMID 20133806 DOI: 10.1073/pnas.0913873107  0.64
2009 Nosov V, Park S, Rao J, Memarzadeh S. Non-Peutz-Jeghers syndrome associated ovarian sex cord tumor with annular tubules: a case report. Fertility and Sterility. 92: 1497.e5-8. PMID 19703688 DOI: 10.1016/j.fertnstert.2009.07.1002  0.64
2008 Lukacs RU, Lawson DA, Xin L, Zong Y, Garraway I, Goldstein AS, Memarzadeh S, Witte ON. Epithelial stem cells of the prostate and their role in cancer progression. Cold Spring Harbor Symposia On Quantitative Biology. 73: 491-502. PMID 19022743 DOI: 10.1101/sqb.2008.73.012  0.64
2007 Memarzadeh S, Xin L, Mulholland DJ, Mansukhani A, Wu H, Teitell MA, Witte ON. Enhanced paracrine FGF10 expression promotes formation of multifocal prostate adenocarcinoma and an increase in epithelial androgen receptor. Cancer Cell. 12: 572-85. PMID 18068633 DOI: 10.1016/j.ccr.2007.11.002  0.64
2003 Memarzadeh S, Natarajan S, Dandade DP, Ostrzega N, Saber PA, Busuttil A, Lentz SE, Berek JS. Lymphovascular and perineural invasion in the parametria: a prognostic factor for early-stage cervical cancer. Obstetrics and Gynecology. 102: 612-9. PMID 12962952 DOI: 10.1016/S0029-7844(03)00569-6  0.64
2003 Memarzadeh S, Lee SB, Berek JS, Farias-Eisner RP. CA125 levels are a weak predictor of optimal cytoreductive surgery in patients with advanced epithelial ovarian cancer International Journal of Gynecological Cancer. 13: 120-124. PMID 12657110 DOI: 10.1046/j.1525-1438.2003.13019.x  0.64
2002 Ide H, Seligson DB, Memarzadeh S, Xin L, Horvath S, Dubey P, Flick MB, Kacinski BM, Palotie A, Witte ON. Expression of colony-stimulating factor 1 receptor during prostate development and prostate cancer progression. Proceedings of the National Academy of Sciences of the United States of America. 99: 14404-9. PMID 12381783 DOI: 10.1073/pnas.222537099  0.64
2002 Memarzadeh S, Holschneider CH, Bristow RE, Jones NL, Fu YS, Karlan BY, Berek JS, Farias-Eisner R. FIGO stage III and IV uterine papillary serous carcinoma: Impact of residual disease on survival International Journal of Gynecological Cancer. 12: 454-458. PMID 12366662 DOI: 10.1046/j.1525-1438.2002.01149.x  0.64
2002 Memarzadeh S, Kozak KR, Chang L, Natarajan S, Shintaku P, Reddy ST, Farias-Eisner R, Memarzedeh S. Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancer. Proceedings of the National Academy of Sciences of the United States of America. 99: 10647-52. PMID 12130664 DOI: 10.1073/pnas.152127499  0.64
2001 Memarzadeh S, Berek JS. Advances in the management of epithelial ovarian cancer Journal of Reproductive Medicine For the Obstetrician and Gynecologist. 46: 621-630. PMID 11499181  0.64
Show low-probability matches.